| Literature DB >> 34599708 |
Micael Widerström1, Marc Stegger2, Anders Johansson3, Bharat Kumar Gurram3, Anders Rhod Larsen2, Lars Wallinder4, Helen Edebro3, Tor Monsen3.
Abstract
Prosthetic joint infection (PJI) is a feared and challenging to diagnose complication after arthroplasty, with Staphylococcus epidermidis as the major pathogen. One important criteria to define PJI is the detection of phenotypically indistinguishable microorganisms with identical antibiotic susceptibility pattern in at least two different samples. However, owing to phenotypical variation within genetic clones and clonal variation within a phenotype, the criteria may be ambiguous. We investigated the extent of diversity among coagulase-negative staphylococci (CoNS) in PJI and characterised S. epidermidis isolates from PJI samples, specifically multiple S. epidermidis isolates identified in individual PJI patients. We performed a retrospective cohort study on 62 consecutive patients with PJI caused by CoNS from two hospitals in Northern Sweden. In 16/62 (26%) PJIs, multiple S. epidermidis isolates were available for whole-genome analyses. Hospital-adapted multidrug-resistant genetic clones of S. epidermidis were identified in samples from 40/62 (65%) of the patients using a combination of pulsed-field gel electrophoresis and multilocus sequence typing. Whole-genome sequencing showed the presence of multiple sequence types (STs) in 7/16 (44%) PJIs where multiple S. epidermidis isolates were available. Within-patient phenotypical variation in the antibiotic susceptibility and/or whole-genome antibiotic resistance gene content was frequent (11/16, 69%) among isolates with the same ST. The results highlight the ambiguity of S. epidermidis phenotypic characterisation as a diagnostic method in PJI and call for larger systematic studies for determining the frequency of CoNS diversity in PJIs, the implications of such diversity for microbiological diagnostics, and the therapeutic outcomes in patients.Entities:
Keywords: Diagnosis; Genomics; Multidrug resistant; Polymicrobial; Prosthetic joint infection; Staphylococcus epidermidis; Within-patient variation
Mesh:
Substances:
Year: 2021 PMID: 34599708 PMCID: PMC8732909 DOI: 10.1007/s10096-021-04352-w
Source DB: PubMed Journal: Eur J Clin Microbiol Infect Dis ISSN: 0934-9723 Impact factor: 3.267
Intra-lineage pairwise single-nucleotide polymorphism Demographic and clinical characteristics of 62 consecutive patients with prosthetic joint infections caused by coagulase-negative staphylococci
| Characteristics | Total (%) |
|---|---|
| Median age (IQR), year | 68.6 (60.5 − 77.5) |
| No. of female patients | 28 (45) |
| Arthroplasty | |
| Hip | 38 (61) |
| Knee | 21 (34) |
| Other: elbow ( | 3 (5) |
| Reason for primary arthroplasty | |
| Osteoarthritis | 36 (60) |
| Fracture or trauma | 15 (32) |
| Rheumatoid arthritis | 11 (8) |
| IDSA PJI criteria | |
| Identical organism identified with two separate cultures | 62 (100) |
| Presence of sinus tract | 9 (15) |
| Visible purulence at implant site | 52 (84) |
| Surgical procedure | 62 (100) |
| Debridement and implant retention | 21 (34) |
| Revision (one-stage exchange) | 6 (10) |
| Resection (two-stage exchange or resection) | 35 (56) |
| Type of revision | |
| Primary | 35 (56) |
| Secondary | 27 (44) |
| Timing from prosthesis implanted to surgery (month) | |
| Early onset (< 3) | 37 (60) |
| Delayed onset (3 to 12) | 11 (18) |
| Late onset (> 12) | 14 (22) |
| Hospitalisation in previous year | |
| Yes | 36 (58) |
| No | 26 (42) |
| Failure of 2-year follow-up | |
| Yes | 15 (24) |
| No | 47 (76) |
IQR inter-quartile range, PJI prosthetic joint infection, IDSA Infectious Disease Society of America
Microbiological characteristics of isolates from 62 consecutive patients with prosthetic joint infections
| Microbiology | Monomicrobial | Polymicrobial | Total |
|---|---|---|---|
| 33 | 19 | 52 | |
| 5 | 0 | 5 | |
| 2 | 3 | 5 | |
| 1 | 1 | 2 | |
| 1 | 0 | 1 | |
| 1 | 0 | 1 | |
| 1 | 1 | ||
| 7 | 7 | ||
| 3 | 3 | ||
| 2 | 2 | ||
| 1 | 1 | ||
| 1 | 1 | ||
| 1 | 1 | ||
| 1 | 1 |
In two cases, three pathogens were identified in multiple tissue biopsies: S. epidermidis, S. aureus, and Enterococcus faecalis (patient ID 10) and S. epidermidis, Escherichia coli, and Enterococcus faecalis (patient ID 47)
Fig. 1Midpoint-rooted maximum-likelihood phylogeny of 69 Staphylococcus epidermidis prosthetic joint infection isolates from 16 patients. Information on sequence type, genes associated with antimicrobial resistance is presented along with the patient number. The scale bar indicates the substitutions per site. The black blocks indicate the presence of genes mediating antibiotic resistance or previously associated with virulence
Within-patient phenotypic and genotypic polymorphisms among 16 patients with prosthetic joint infection caused by Staphylococcus epidermidis with more than two isolates, as analysed using whole-genome sequencing
| Patient ID | Type of implant | Classificationa | No. of specimens included | No. of | No. of different antibiograms | Sequence type(s) | Polymicrobial | Additional species |
|---|---|---|---|---|---|---|---|---|
| 2 | Hip | Early | 7 | 9 | 1 | 2 | No | |
| 12 | Hip | Early | 3 | 3 | 2 | 2, 73 | Yes | |
| 28 | Hip | Early | 2 | 2 | 2 | 2 | No | |
| 46 | Hip | Early | 2 | 2 | 1 | 89 | No | |
| 47 | Hip | Delayed | 2 | 2 | 1 | 2 | Yes | |
| 50 | Hip | Delayed | 2 | 2 | 2 | 215, 434 | Yes | |
| 56 | Hip | Delayed | 2 | 3 | 2 | 2 | No | |
| 1 | Hip | Late | 4 | 8 | 5 | 59, 215 | Yes | |
| 40 | Hip | Late | 4 | 4 | 2 | 215 | Yes | |
| 43 | Knee | Early | 5 | 5 | 2 | 2 | No | |
| 54 | Knee | Early | 6 | 7 | 3 | 225, 434, 723, 962, 964 | Yes | |
| 58 | Knee | Early | 3 | 3 | 3 | 2, 188 | No | |
| 60 | Knee | Early | 2 | 2 | 2 | 5, 86 | Yes | |
| 42 | Knee | Delayed | 4 | 4 | 2 | 188 | No | |
| 49 | Knee | Late | 7 | 7 | 3 | 965 | No | |
| 37 | Shoulder | Late | 5 | 6 | 4 | 2, 152, 215, 961 | No |
aEarly = < 3 months, delayed = 3–12 months, late = > 12 months
Fig. 2Pairwise within-patient single-nucleotide polymorphism distances among 16 patients with prosthetic joint infection, with more than two Staphylococcus epidermidis isolates available for analysis. Different colours indicate different sequence types
Fig. 3Pairwise single-nucleotide polymorphism (SNP) within-patient and between-patients SNP distances among prosthetic joint infection Staphylococcus epidermidis isolates from ST2/ST188, ST59/ST965, and ST215/ST434. ****p < 0.0001, **p = 0.002
Within-patient polymorphism in phenotypic antimicrobial susceptibility patterns among 16 patients with prosthetic joint infections with more than two isolates of Staphylococcus epidermidis
| Patient ID | ST | Isolates ( | Antimicrobial | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| FUS | FOX | GEN | CLI | ERY | NOR | RIF | SXT | |||
| 1 | 59 | 1 | R | S | S | S | S | S | S | S |
| 215 | 2 | R | S | R | R | R | R | S | R | |
| 215 | 1 | R | R | R | S | S | R | S | R | |
| 215 | 2 | R | S | R | S | S | R | S | R | |
| 215 | 2 | R | R | R | R | R | R | S | R | |
| 2 | 2 | 9 | S | R | R | R | R | R | R | R |
| 12 | 2 | 2 | S | R | R | R | R | R | R | R |
| 73 | 1 | S | S | S | S | S | S | S | S | |
| 28 | 2 | 1 | S | R | S | R | R | R | S | R |
| 2 | 1 | R | R | R | R | R | R | S | R | |
| 37 | 2 | 1 | S | S | R | R | R | R | R | R |
| 2 | 2 | S | R | R | S | S | R | R | R | |
| 152 | 1 | S | S | S | S | S | S | S | S | |
| 215 | 1 | R | R | R | R | R | R | S | R | |
| 961 | 1 | S | S | S | S | S | S | S | S | |
| 40 | 215 | 3 | R | R | R | S | S | R | S | R |
| 215 | 1 | R | S | R | R | R | R | S | R | |
| 42 | 188 | 3 | R | R | R | R | R | R | S | R |
| 188 | 1 | R | R | R | S | S | R | S | R | |
| 43 | 2 | 4 | S | R | R | R | R | R | S | R |
| 2 | 1 | S | R | R | S | S | R | S | R | |
| 46 | 89 | 2 | S | S | R | S | S | S | S | S |
| 47 | 2 | 2 | S | R | R | R | R | R | S | R |
| 49 | 965 | 5 | S | R | R | S | S | S | S | S |
| 965 | 1 | R | R | R | S | R | S | S | S | |
| 965 | 1 | S | R | R | S | R | S | S | S | |
| 50 | 215 | 1 | R | R | R | R | R | R | S | R |
| 434 | 1 | R | R | R | R | R | R | R | R | |
| 54 | 225 | 1 | S | S | S | S | S | S | S | S |
| 434 | 3 | R | R | R | R | R | R | R | R | |
| 723 | 1 | S | S | R | S | S | S | S | S | |
| 962 | 1 | S | S | S | S | S | S | S | S | |
| 964 | 1 | S | S | S | S | S | S | S | S | |
| 56 | 2 | 2 | S | R | R | S | S | R | R | R |
| 2 | 1 | S | R | R | R | R | R | R | R | |
| 58 | 2 | 1 | S | R | R | R | R | R | S | R |
| 2 | 1 | S | R | R | R | R | R | R | R | |
| 188 | 1 | R | R | R | R | R | R | R | R | |
| 60 | 5 | 1 | S | S | R | S | R | S | S | S |
| 86 | 1 | S | S | R | S | S | S | R | S | |
GEN gentamicin, CLI clindamycin, ERY erythromycin, FUS fusidic acid, FOX cefoxitin, NOR norfloxacin, RIF rifampicin, SXT trimethoprim-sulfamethoxazole, R resistant, S susceptible